Company Financial Performance: Revenue, profitability, and growth prospects significantly influence investor confidence and stock price.

Industry Trends: The overall health and outlook of the pharmaceutical industry, including innovation and regulatory changes, impact investor sentiment.

Regulatory Environment: Changes in drug approval processes, patent laws, and pricing regulations can affect the company's future earnings and stock price.

Market Sentiment: General market conditions, economic indicators, and investor psychology play a role in determining stock valuations.

Competition: The presence of competing drugs or companies and their relative success influences the company's market share and stock performance.

News and Events: Significant announcements, such as clinical trial results, partnerships, or acquisitions, can cause fluctuations in the stock price.

Overall Economy: Economic growth, inflation, and interest rates can affect consumer spending on healthcare and investor attitudes towards risk.

Drug Pricing: Changes to pricing laws and the impact on profitability affect the company's potential.